Dr. Fabiana Dellai | Antimicrobial stewardship | Young Scientist Award
Resident, Infectious Disease Departement, Azienda Sanitaria Friuli Centrale (ASUFC), Italy 🩺
Dr. Fabiana Dellai is a dedicated physician specializing in Infectious and Tropical Diseases. With a strong medical background, she has actively contributed to healthcare, particularly in managing infectious diseases and pandemic responses. Her expertise extends to research, where she has published several impactful studies on COVID-19, antimicrobial resistance, and hospital infections. Dr. Dellai is committed to advancing medical knowledge and patient care, blending her clinical experience with scientific research.
Profile
Education 🎓
Dr. Fabiana Dellai holds a Doctor of Medicine and Surgery (MD) degree from the University of Verona, obtained in 2020. She later earned her Medical License Qualification from the same institution in July 2020. Currently, she is pursuing a specialization in Infectious and Tropical Diseases at the University of Udine (2021-2025). Her strong academic foundation began with a Classical High School Diploma from Liceo Scientifico Galileo Galilei, Trento.
Professional Experience 💼
Dr. Dellai has served in multiple roles as an independent physician and general practitioner. She provided critical medical support during the COVID-19 pandemic at Ospedale S. Chiara, Trento. Additionally, she has worked as a General Practitioner Substitute for various medical professionals, ensuring continuous patient care. Her experience spans primary healthcare, infectious disease management, and hospital-based medicine.
Research Interests 🔬
Dr. Dellai’s research focuses on infectious diseases, antimicrobial resistance, COVID-19, and hospital-acquired infections. She has investigated the impact of multidrug-resistant bacteria (MDR, XDR, PDR), post-COVID syndromes, and precision medicine for targeted antibiotic therapy. Her studies contribute to the development of more effective treatments and infection control strategies.
Awards & Recognitions 🏆
Dr. Dellai has been recognized for her contributions to infectious disease research and clinical practice. She has actively participated in international congresses and scientific collaborations, presenting her research at ECCMID and ESCMID Global Conferences. Her work has been acknowledged in leading medical journals and has influenced advancements in infectious disease treatment.
Publications 📚
1️⃣ Systemic Capillary Leak Syndrome triggered by SARS-CoV-2 infection: Case Report and Systematic Review (2022)
📄 Scandinavian Journal of Rheumatology | Cited by: Various articles
2️⃣ Post-COVID-19 Syndrome and Humoral Response Association After 1 Year in Vaccinated and Unvaccinated Patients (2022)
📄 Clinical Microbiology and Infection | Cited by: Multiple studies
3️⃣ High Dimensional Feature Selection Using Informative Distance Measures: Application to COVID-19 Severity Prediction (2022)
📄 Preprint on Research Square
4️⃣ Potential Role of IgM-Enriched Immunoglobulin as Adjuvant Treatment in Severe SARS-CoV-2 Infection (2023)
📄 Minerva Anestesiologica
5️⃣ Management of Intra-Abdominal Infections: Recommendations by the Italian Council for the Optimization of Antimicrobial Use (2024)
📄 World Journal of Emergency Surgery
6️⃣ A Precision Medicine Model for Targeted Antibiotic Therapy in Urinary Tract Infections (2025)
📄 Antibiotics
Conclusion
Dr. Fabiana Dellai is a highly suitable candidate for the Research for Young Scientist Award. Her strong foundation in infectious disease research, clinical contributions, and innovative studies make her a deserving nominee. With continued advancements in funding, collaborations, and mentorship, she can further elevate her scientific impact. 🏆